Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It began promoting MERREM I.V. (meropenem for injection) in the U.S. in July 2008. MERREM is an established spectrum antibiotic developed by AstraZeneca. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials; CONSERV-1 and CONSERV-2 for the reduction of blood loss during cardiac surgery; and two Phase 1 programs that address unmet medical needs, one in CDAD (Clostridium difficile-associated diarrhea) and the other in multi-drug resistant (MDR) Gram-negative infections. In addition, the company, in collaboration with Alnylam Pharmaceuticals, Inc., has a pre-IND and a Phase 2 program underway in novel treatments for respiratory syncytial virus infections using Alnylam's RNA-interference technology. Cubist was founded in 1992 and is headquartered in Lexington, Massachusetts.The staff at Cubist Pharmaceuticals come from unusually diverse demographic backgrounds. The company is 47.9% female and 39.8% ethnic minorities. Cubist Pharmaceuticals employees are slightly more likely to be members of the Democratic Party than the Republican Party, with 60.0% of employees identifying as members of the Democratic Party. Despite their political differences, employees at Cubist Pharmaceuticals seem to be happy. The company has great employee retention with staff members usually staying for 3.8 years.The average employee at Cubist Pharmaceuticals makes $91,725 per year. Pay at Cubist Pharmaceuticals is significantly lower than some of its highest paying competitors, like Karyopharm, Incyte, and Bristol-Myers Squibb, which pay $107,666, $103,592, and $101,824, respectively.Cubist Pharmaceuticals is a medium pharmaceutical company with 873 employees and an annual revenue of $926.4M that is headquartered in Massachusetts.
Cubist Pharmaceuticals's mission statement
To discover, develop and provide innovative products and services that save and improve lives around the world.
In demand companies are hiring! Let Zippia apply for you!
-
Cubist Pharmaceuticals employee reviews
Be the first to review!
Do you work at Cubist Pharmaceuticals?
Help job seekers learn about working at Cubist Pharmaceuticals
The founders of Cubist Pharmaceuticals are John Clarke and Paul Schimmel.
The key people at Cubist Pharmaceuticals are Michael Bonney, John Clarke and Paul Schimmel.
Key people
Michael Bonney
John Clarke
Paul Schimmel
Cubist Pharmaceuticals rankings
Cubist Pharmaceuticals is ranked #39 on the Best Pharmaceutical companies to work for in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Rate Cubist Pharmaceuticals' commitment to diversity and inclusion.
Cubist Pharmaceuticals diversity
9.9
Diversity score
We calculated Cubist Pharmaceuticals’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Cubist Pharmaceuticals’s workforce.
Cubist Pharmaceuticals diversity summary. Zippia estimates Cubist Pharmaceuticals's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Cubist Pharmaceuticals's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Cubist Pharmaceuticals's workforce.
Cubist Pharmaceuticals has 873 employees.
48% of Cubist Pharmaceuticals employees are women, while 52% are men.
The most common ethnicity at Cubist Pharmaceuticals is White (60%).
17% of Cubist Pharmaceuticals employees are Asian.
12% of Cubist Pharmaceuticals employees are Hispanic or Latino.
The average employee at Cubist Pharmaceuticals makes $91,725 per year.
Cubist Pharmaceuticals employees are most likely to be members of the democratic party.
Employees at Cubist Pharmaceuticals stay with the company for 3.8 years on average.
Do you work at Cubist Pharmaceuticals?
Does Cubist Pharmaceuticals actively promote diversity and inclusion?
Cubist Pharmaceuticals financial performance
9.8
Performance score
Highest paying Cubist Pharmaceuticals competitors
Compare Cubist Pharmaceuticals salaries to competitors, including Karyopharm, Incyte, and Bristol-Myers Squibb. Employees at Karyopharm earn the highest average yearly salary of $107,666. The salaries at Incyte average $103,592 per year, and the salaries at Bristol-Myers Squibb come in at $101,824 per year.
Rank
Company
Average salary
Jobs
1
$107,666
0
2
$103,592
0
3
$101,824
0
4
$99,828
0
5
$95,952
0
6
$94,078
0
7
$93,524
0
8
$93,461
0
9
$90,328
0
10
$89,038
0
Show more
Are you an executive, HR leader, or brand manager at Cubist Pharmaceuticals?
Claiming and updating your company profile on Zippia is free and easy.
Cubist Pharmaceuticals FAQs
When was Cubist Pharmaceuticals founded?
How many employees does Cubist Pharmaceuticals have?
Zippia gives an in-depth look into the details of Cubist Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cubist Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cubist Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cubist Pharmaceuticals. The data presented on this page does not represent the view of Cubist Pharmaceuticals and its employees or that of Zippia.
Cubist Pharmaceuticals may also be known as or be related to Cubist Pharmaceuticals, Cubist Pharmaceuticals INC, Cubist Pharmaceuticals LLC, Cubist Pharmaceuticals, INC and Cubist Pharmaceuticals, Inc.